NIH Grants for Exploratory Investigations on Primary Immunodeficiency Diseases (R03)

Opportunity ID: 43979

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-07-447
Funding Opportunity Title: Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R03)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.839 — Blood Diseases and Resources Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 4
Posted Date: Dec 05, 2008
Last Updated Date: Oct 15, 2009
Original Closing Date for Applications: – Multiple Receipt Dates – See Link to Full Announcement for details.
Current Closing Date for Applications: May 07, 2010 Multiple Receipt Dates – See Link to Full Announcement for details.
Archive Date: Jun 07, 2010
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
Native American tribal governments (Federally recognized)
Small businesses
State governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Private institutions of higher education
County governments
Independent school districts
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.

Additional Information

Agency Name: National Institutes of Health
Description: Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to support small grants in primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models, including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases. Typical grants propose pilot and feasibility studies, secondary analysis of existing data, small, self-contained research projects, development of research methodology, or development of new research technology. Investigators who have no prior history of receiving independent NIH funding or no prior history of receiving independent NIH funding in primary immunodeficiency diseases research, are encouraged to apply to this FOA. Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) grant mechanism and runs in parallel with a FOA of identical scientific scope, PAR-07-446, that solicits applications under the R21 grant mechanism. Funds Available and Anticipated Number of Awards. It is anticipated that $0.2 million per year will be available under this FOA and that 3 new awards will be made each year. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Budget and Project Period. Budgets for direct costs up to $50,000 per year and a project duration of up to two years may be requested for a maximum of $100,000 direct costs over a two-year project period. The R03 is not renewable. Eligible Institutions/Organizations. Public/State Controlled Institution of Higher Education; Private Institution of Higher Education; Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education); Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education); Small Business; For-Profit Organization (Other than Small Business); State Government; U.S. Territory or Possession; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); Indian/Native American Tribally Designated Organization; Non-domestic (non-U.S.) Entity (Foreign Organization); Hispanic-serving Institution; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); Alaska Native and Native Hawaiian Serving Institutions; Regional Organization; Eligible agencies of the Federal government; Faith-based or community based organizations.) Eligible Project Directors/Principal Investigators (PDs/PIs): Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Renewals and Resubmissions. The R03 is not renewable. Up to two resubmissions (formerly revisions/amendments”) of a previously reviewed small grant application may be submitted as defined in NIH Policy. See NOT-OD-05-046. Number of PDs/PIs: More than one PD/PI, or multiple PDs/PIs, may be designated on the application. Number of Applications. An applicant may serve as a PD/PI on only one application submitted in response to this FOA for each receipt date. A single institution is permitted to submit more than one application provided each application is scientifically distinct.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-07-447.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date
changed expiration date Oct 15, 2009
Modified Archive Date based on new Expiration Date. Oct 15, 2009
modified exp date to 11/20/2009, changed archive date to reflect 12/21/2009. Dec 05, 2008
Dec 05, 2008

DISPLAYING: Synopsis 4

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-07-447
Funding Opportunity Title: Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R03)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.839 — Blood Diseases and Resources Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 4
Posted Date: Dec 05, 2008
Last Updated Date: Oct 15, 2009
Original Closing Date for Applications: – Multiple Receipt Dates – See Link to Full Announcement for details.
Current Closing Date for Applications: May 07, 2010 Multiple Receipt Dates – See Link to Full Announcement for details.
Archive Date: Jun 07, 2010
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
Native American tribal governments (Federally recognized)
Small businesses
State governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Private institutions of higher education
County governments
Independent school districts
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.

Additional Information

Agency Name: National Institutes of Health
Description: Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to support small grants in primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models, including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases. Typical grants propose pilot and feasibility studies, secondary analysis of existing data, small, self-contained research projects, development of research methodology, or development of new research technology. Investigators who have no prior history of receiving independent NIH funding or no prior history of receiving independent NIH funding in primary immunodeficiency diseases research, are encouraged to apply to this FOA. Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) grant mechanism and runs in parallel with a FOA of identical scientific scope, PAR-07-446, that solicits applications under the R21 grant mechanism. Funds Available and Anticipated Number of Awards. It is anticipated that $0.2 million per year will be available under this FOA and that 3 new awards will be made each year. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Budget and Project Period. Budgets for direct costs up to $50,000 per year and a project duration of up to two years may be requested for a maximum of $100,000 direct costs over a two-year project period. The R03 is not renewable. Eligible Institutions/Organizations. Public/State Controlled Institution of Higher Education; Private Institution of Higher Education; Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education); Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education); Small Business; For-Profit Organization (Other than Small Business); State Government; U.S. Territory or Possession; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); Indian/Native American Tribally Designated Organization; Non-domestic (non-U.S.) Entity (Foreign Organization); Hispanic-serving Institution; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); Alaska Native and Native Hawaiian Serving Institutions; Regional Organization; Eligible agencies of the Federal government; Faith-based or community based organizations.) Eligible Project Directors/Principal Investigators (PDs/PIs): Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Renewals and Resubmissions. The R03 is not renewable. Up to two resubmissions (formerly revisions/amendments”) of a previously reviewed small grant application may be submitted as defined in NIH Policy. See NOT-OD-05-046. Number of PDs/PIs: More than one PD/PI, or multiple PDs/PIs, may be designated on the application. Number of Applications. An applicant may serve as a PD/PI on only one application submitted in response to this FOA for each receipt date. A single institution is permitted to submit more than one application provided each application is scientifically distinct.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-07-447.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 3

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-07-447
Funding Opportunity Title: Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R03)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.839 — Blood Diseases and Resources Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: Oct 15, 2009
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Feb 16, 2010 Multiple Receipt Dates – See Link to Full Announcement for details.
Archive Date: Mar 16, 2010
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Native American tribal governments (Federally recognized)
Special district governments
Public housing authorities/Indian housing authorities
Small businesses
City or township governments
State governments
For profit organizations other than small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Public and State controlled institutions of higher education
Private institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.

Additional Information

Agency Name: National Institutes of Health
Description: Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to support small grants in primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models, including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases. Typical grants propose pilot and feasibility studies, secondary analysis of existing data, small, self-contained research projects, development of research methodology, or development of new research technology. Investigators who have no prior history of receiving independent NIH funding or no prior history of receiving independent NIH funding in primary immunodeficiency diseases research, are encouraged to apply to this FOA. Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) grant mechanism and runs in parallel with a FOA of identical scientific scope, PAR-07-446, that solicits applications under the R21 grant mechanism. Funds Available and Anticipated Number of Awards. It is anticipated that $0.2 million per year will be available under this FOA and that 3 new awards will be made each year. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Budget and Project Period. Budgets for direct costs up to $50,000 per year and a project duration of up to two years may be requested for a maximum of $100,000 direct costs over a two-year project period. The R03 is not renewable. Eligible Institutions/Organizations. Public/State Controlled Institution of Higher Education; Private Institution of Higher Education; Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education); Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education); Small Business; For-Profit Organization (Other than Small Business); State Government; U.S. Territory or Possession; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); Indian/Native American Tribally Designated Organization; Non-domestic (non-U.S.) Entity (Foreign Organization); Hispanic-serving Institution; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); Alaska Native and Native Hawaiian Serving Institutions; Regional Organization; Eligible agencies of the Federal government; Faith-based or community based organizations.) Eligible Project Directors/Principal Investigators (PDs/PIs): Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Renewals and Resubmissions. The R03 is not renewable. Up to two resubmissions (formerly revisions/amendments”) of a previously reviewed small grant application may be submitted as defined in NIH Policy. See NOT-OD-05-046. Number of PDs/PIs: More than one PD/PI, or multiple PDs/PIs, may be designated on the application. Number of Applications. An applicant may serve as a PD/PI on only one application submitted in response to this FOA for each receipt date. A single institution is permitted to submit more than one application provided each application is scientifically distinct.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-07-447.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-07-447
Funding Opportunity Title: Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R03)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.839 — Blood Diseases and Resources Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Dec 05, 2008
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Nov 20, 2009 Multiple Receipt Dates – See Link to Full Announcement for details.
Archive Date: Dec 21, 2009
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Native American tribal governments (Federally recognized)
Special district governments
Public housing authorities/Indian housing authorities
Small businesses
City or township governments
State governments
For profit organizations other than small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Public and State controlled institutions of higher education
Private institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.

Additional Information

Agency Name: National Institutes of Health
Description: Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to support small grants in primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models, including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases. Typical grants propose pilot and feasibility studies, secondary analysis of existing data, small, self-contained research projects, development of research methodology, or development of new research technology. Investigators who have no prior history of receiving independent NIH funding or no prior history of receiving independent NIH funding in primary immunodeficiency diseases research, are encouraged to apply to this FOA. Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) grant mechanism and runs in parallel with a FOA of identical scientific scope, PAR-07-446, that solicits applications under the R21 grant mechanism. Funds Available and Anticipated Number of Awards. It is anticipated that $0.2 million per year will be available under this FOA and that 3 new awards will be made each year. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Budget and Project Period. Budgets for direct costs up to $50,000 per year and a project duration of up to two years may be requested for a maximum of $100,000 direct costs over a two-year project period. The R03 is not renewable. Eligible Institutions/Organizations. Public/State Controlled Institution of Higher Education; Private Institution of Higher Education; Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education); Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education); Small Business; For-Profit Organization (Other than Small Business); State Government; U.S. Territory or Possession; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); Indian/Native American Tribally Designated Organization; Non-domestic (non-U.S.) Entity (Foreign Organization); Hispanic-serving Institution; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); Alaska Native and Native Hawaiian Serving Institutions; Regional Organization; Eligible agencies of the Federal government; Faith-based or community based organizations.) Eligible Project Directors/Principal Investigators (PDs/PIs): Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Renewals and Resubmissions. The R03 is not renewable. Up to two resubmissions (formerly revisions/amendments”) of a previously reviewed small grant application may be submitted as defined in NIH Policy. See NOT-OD-05-046. Number of PDs/PIs: More than one PD/PI, or multiple PDs/PIs, may be designated on the application. Number of Applications. An applicant may serve as a PD/PI on only one application submitted in response to this FOA for each receipt date. A single institution is permitted to submit more than one application provided each application is scientifically distinct.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-07-447.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-07-447
Funding Opportunity Title: Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R03)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.839 — Blood Diseases and Resources Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 05, 2008
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: – Multiple Receipt Dates – See Link to Full Announcement for details.
Archive Date: Dec 21, 2010
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Native American tribal governments (Federally recognized)
Special district governments
Public housing authorities/Indian housing authorities
Small businesses
City or township governments
State governments
For profit organizations other than small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Private institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.

Additional Information

Agency Name: National Institutes of Health
Description: Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to support small grants in primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models, including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases. Typical grants propose pilot and feasibility studies, secondary analysis of existing data, small, self-contained research projects, development of research methodology, or development of new research technology. Investigators who have no prior history of receiving independent NIH funding or no prior history of receiving independent NIH funding in primary immunodeficiency diseases research, are encouraged to apply to this FOA. Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) grant mechanism and runs in parallel with a FOA of identical scientific scope, PAR-07-446, that solicits applications under the R21 grant mechanism. Funds Available and Anticipated Number of Awards. It is anticipated that $0.2 million per year will be available under this FOA and that 3 new awards will be made each year. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Budget and Project Period. Budgets for direct costs up to $50,000 per year and a project duration of up to two years may be requested for a maximum of $100,000 direct costs over a two-year project period. The R03 is not renewable. Eligible Institutions/Organizations. Public/State Controlled Institution of Higher Education; Private Institution of Higher Education; Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education); Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education); Small Business; For-Profit Organization (Other than Small Business); State Government; U.S. Territory or Possession; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); Indian/Native American Tribally Designated Organization; Non-domestic (non-U.S.) Entity (Foreign Organization); Hispanic-serving Institution; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); Alaska Native and Native Hawaiian Serving Institutions; Regional Organization; Eligible agencies of the Federal government; Faith-based or community based organizations.) Eligible Project Directors/Principal Investigators (PDs/PIs): Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Renewals and Resubmissions. The R03 is not renewable. Up to two resubmissions (formerly revisions/amendments”) of a previously reviewed small grant application may be submitted as defined in NIH Policy. See NOT-OD-05-046. Number of PDs/PIs: More than one PD/PI, or multiple PDs/PIs, may be designated on the application. Number of Applications. An applicant may serve as a PD/PI on only one application submitted in response to this FOA for each receipt date. A single institution is permitted to submit more than one application provided each application is scientifically distinct.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-07-447.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
ADOBE-FORMS-A Adobe-Forms-A PKG00009327 Dec 05, 2008 Jan 20, 2010 View
ADOBE-FORMS-B Use for submissions intended for due dates of January 25, 2010 and beyond PKG00015314 Dec 21, 2009 May 07, 2010 View

Package 1

Mandatory forms

43979 RR_SF424-1.1.pdf

43979 RR_KeyPersonExpanded-1.1.pdf

43979 RR_OtherProjectInfo-1.1.pdf

43979 RR_PerformanceSite-1.1.pdf

43979 PHS398_CoverPageSupplement-1.1.pdf

43979 PHS398_ResearchPlan-1.1.pdf

43979 PHS398_Checklist-1.1.pdf

Optional forms

43979 PHS398_CoverLetter-1.1.pdf

43979 PHS398_ModularBudget-1.1.pdf

43979 RR_Budget-1.1.pdf

43979 RR_SubawardBudget-1.2.pdf

Package 2

Mandatory forms

43979 RR_SF424_1_2-1.2.pdf

43979 PerformanceSite_1_3-1.3.pdf

43979 RR_OtherProjectInfo_1_2-1.2.pdf

43979 RR_KeyPersonExpanded_1_2-1.2.pdf

43979 PHS398_CoverPageSupplement_1_4-1.4.pdf

43979 PHS398_ResearchPlan_1_3-1.3.pdf

43979 PHS398_Checklist_1_3-1.3.pdf

Optional forms

43979 PHS_CoverLetter_1_2-1.2.pdf

43979 PHS398_ModularBudget-1.1.pdf

43979 RR_Budget-1.1.pdf

43979 RR_SubawardBudget-1.2.pdf


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *